Trending...
- Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series - 142
- Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets - 126
- Shoutout Joseph Neibich aka Nybyk
FOR IMMEDIATE RELEASE
July 20, 2021
Contact: Kathleen Achtenberg, achtenbergk@michigan.org
Gov. Gretchen Whitmer announces Piramal Pharma Solutions expanding in SE Michigan, creating 31 high-wage jobs
LANSING, Mich. - Gov. Gretchen Whitmer joined the Michigan Economic Development Corporation today to announce that contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS) plans to expand in Riverview with support from the Michigan Strategic Fund, signaling continued economic recovery and the growth of the life sciences and healthcare industry in Michigan.
The project is expected to generate a total private investment of $35 million and create 31 high-wage jobs, resulting in a $200,000 Jobs Ready Michigan performance-based grant. Michigan was chosen for the project over another of the company's sites in Europe.
"Piramal Pharma Solutions' decision to expand in Southeast Michigan will create good-paying jobs for our talented workforce," said Governor Gretchen Whitmer. "Their expansion underscores the strength of Michigan's business climate and continued leadership in manufacturing across industry sectors. This is great news for workers and their families as we continue our economic jumpstart and put Michigan back to work. With the help of companies like PPS, we can put Michigan first and build back our state's economy stronger than ever before."
Piramal Pharma Solutions partners with and provides support to pharmaceutical companies as they seek FDA approval for new drug applications. The Riverview site, originally established as Ash Stevens in 1962, specializes in the development and manufacture of high-potency active pharmaceutical ingredients (HPAPIs), with an emphasis on oncology applications. It's a key site in the company's integrated offering, which combines services across a global network of sites to offer speed and simplicity to companies innovating new medicines for patients. Ash Stevens was acquired by Piramal Pharma Solutions in 2016, which has led to a significant increase in revenue and number of employees.
"The Riverview, Michigan site is an extremely important part of our global network, since it produces the active ingredients used in a number of developmental and commercial pharmaceutical treatments," said Piramal Pharma Solutions Chief Executive Officer Peter DeYoung. "This expansion enables us to better serve our current customers and meet additional market demand for drug substances, including HPAPIs, furthering our efforts to reduce the burden of disease on patients around the world."
In response to the increasing need for high potency APIs and the corresponding growth at the Riverview site, PPS plans to establish a new facility on an adjacent property that will house manufacturing, warehousing and laboratory operations. With the help of the Jobs Ready Michigan performance-based grant, PPS will be able to offer above-market salaries to attract and retain the talent it needs.
More on Michimich.com
"Michigan is grateful for Piramal Pharma Solutions' continued vote of confidence in our state and in our workforce. The message is clear: Michigan's economy is recovering, and we will continue to work building a championship economy here in the state," said Quentin Messer, Jr., CEO of the Michigan Economic Development Corporation and President and Chair of the Michigan Strategic Fund. "We appreciate the efforts of our local partners in Wayne County to support this project and will work with PPS over the coming months and years as it continues to grow and add jobs for Michigan residents."
The Jobs Ready Michigan Program is designed to provide grants for business expansion and location projects that lead to job creation and investments in Michigan that have a demonstrated training need, particularly in pursuing new opportunities for high-tech, high-demand, and high-wage jobs.
The project further strengthens Michigan's life sciences and healthcare industry and will bring high-wage, high-skill jobs to area residents, including positions such as chemists, quality assurance specialists, and R&D scientists.
"The growth of the Piramal Pharma Solutions site in Riverview is representative of Wayne County's versatility in expanding industries," said Wayne County Executive Warren Evans. "We look forward to supporting their expansion, which will bring 31 new jobs and a capital investment of up to $35 million to the city of Riverview and Wayne County."
For information on careers with Piramal Pharma Solutions, visit https://www.piramalpharmasolutions.com/careers.
About Michigan Economic Development Corporation (MEDC)
The Michigan Economic Development Corporation is the state's marketing arm and lead advocate for business development, job awareness and community development with the focus on growing Michigan's economy. For more information on the MEDC and our initiatives, visit www.MichiganBusiness.org. For Pure Michigan® tourism information, your trip begins at www.michigan.org. Join the conversation on: Facebook, Instagram, LinkedIn, and Twitter.
More on Michimich.com
About Piramal Pharma Solutions:
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.
For more information please visit: www.piramalpharmasolutions.com | Twitter | LinkedIn
July 20, 2021
Contact: Kathleen Achtenberg, achtenbergk@michigan.org
Gov. Gretchen Whitmer announces Piramal Pharma Solutions expanding in SE Michigan, creating 31 high-wage jobs
- Full-service contract development and manufacturing organization will add 31 new jobs and invest $35 million in Riverview with support from the Michigan Strategic Fund
- Project solidifies company's presence in state, further strengthens Michigan's life sciences and healthcare industry
LANSING, Mich. - Gov. Gretchen Whitmer joined the Michigan Economic Development Corporation today to announce that contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS) plans to expand in Riverview with support from the Michigan Strategic Fund, signaling continued economic recovery and the growth of the life sciences and healthcare industry in Michigan.
The project is expected to generate a total private investment of $35 million and create 31 high-wage jobs, resulting in a $200,000 Jobs Ready Michigan performance-based grant. Michigan was chosen for the project over another of the company's sites in Europe.
"Piramal Pharma Solutions' decision to expand in Southeast Michigan will create good-paying jobs for our talented workforce," said Governor Gretchen Whitmer. "Their expansion underscores the strength of Michigan's business climate and continued leadership in manufacturing across industry sectors. This is great news for workers and their families as we continue our economic jumpstart and put Michigan back to work. With the help of companies like PPS, we can put Michigan first and build back our state's economy stronger than ever before."
Piramal Pharma Solutions partners with and provides support to pharmaceutical companies as they seek FDA approval for new drug applications. The Riverview site, originally established as Ash Stevens in 1962, specializes in the development and manufacture of high-potency active pharmaceutical ingredients (HPAPIs), with an emphasis on oncology applications. It's a key site in the company's integrated offering, which combines services across a global network of sites to offer speed and simplicity to companies innovating new medicines for patients. Ash Stevens was acquired by Piramal Pharma Solutions in 2016, which has led to a significant increase in revenue and number of employees.
"The Riverview, Michigan site is an extremely important part of our global network, since it produces the active ingredients used in a number of developmental and commercial pharmaceutical treatments," said Piramal Pharma Solutions Chief Executive Officer Peter DeYoung. "This expansion enables us to better serve our current customers and meet additional market demand for drug substances, including HPAPIs, furthering our efforts to reduce the burden of disease on patients around the world."
In response to the increasing need for high potency APIs and the corresponding growth at the Riverview site, PPS plans to establish a new facility on an adjacent property that will house manufacturing, warehousing and laboratory operations. With the help of the Jobs Ready Michigan performance-based grant, PPS will be able to offer above-market salaries to attract and retain the talent it needs.
More on Michimich.com
- On the 296th Anniversary of the Ceremony That Made His Ancestor Emperor, a Cherokee Descendant Publishes the Novel That Restores Him
- NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
- DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model
- CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
- Explosive $10 Billion Counter-Drone Market with AI-Powered Defense Ecosystem: ZenaTech, Inc. (N A S D A Q: ZENA)
"Michigan is grateful for Piramal Pharma Solutions' continued vote of confidence in our state and in our workforce. The message is clear: Michigan's economy is recovering, and we will continue to work building a championship economy here in the state," said Quentin Messer, Jr., CEO of the Michigan Economic Development Corporation and President and Chair of the Michigan Strategic Fund. "We appreciate the efforts of our local partners in Wayne County to support this project and will work with PPS over the coming months and years as it continues to grow and add jobs for Michigan residents."
The Jobs Ready Michigan Program is designed to provide grants for business expansion and location projects that lead to job creation and investments in Michigan that have a demonstrated training need, particularly in pursuing new opportunities for high-tech, high-demand, and high-wage jobs.
The project further strengthens Michigan's life sciences and healthcare industry and will bring high-wage, high-skill jobs to area residents, including positions such as chemists, quality assurance specialists, and R&D scientists.
"The growth of the Piramal Pharma Solutions site in Riverview is representative of Wayne County's versatility in expanding industries," said Wayne County Executive Warren Evans. "We look forward to supporting their expansion, which will bring 31 new jobs and a capital investment of up to $35 million to the city of Riverview and Wayne County."
For information on careers with Piramal Pharma Solutions, visit https://www.piramalpharmasolutions.com/careers.
About Michigan Economic Development Corporation (MEDC)
The Michigan Economic Development Corporation is the state's marketing arm and lead advocate for business development, job awareness and community development with the focus on growing Michigan's economy. For more information on the MEDC and our initiatives, visit www.MichiganBusiness.org. For Pure Michigan® tourism information, your trip begins at www.michigan.org. Join the conversation on: Facebook, Instagram, LinkedIn, and Twitter.
More on Michimich.com
- High-Value Execution Phase Begins: Bitcoin Bancorp Ignites Texas Rollout of Digital Asset ATM Network: Bitcoin Bancorp (Stock Symbol: BCBC) $BCBC
- UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
- SelfCare is now HealthCare across America
- Christian Confessional Challenge - Anton Williams Holding Co
- Practical Theology in Post Modernity - Anton Williams
About Piramal Pharma Solutions:
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.
For more information please visit: www.piramalpharmasolutions.com | Twitter | LinkedIn
0 Comments
Latest on Michimich.com
- Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
- The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
- Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
- Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
- New Book Reveals The Science Of Predictions
- Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
- Reozom Expands Flat Fee MLS Services in Florida and Michigan with Digital Listing Platform
- Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
- NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
- EFA Announces 2026 Editorial Rate Chart
- Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
- Shoutout Joseph Neibich aka Nybyk
- Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- Image Printing Company, Inc. Awarded GSA Multiple Award Schedule Contract, Expanding Federal Printing Capabilities
- Logicalis US Named to CRN's Tech Elite 250 for 2026
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)